Rhodri Smith

Rhodri Smith

Auto-generated profile, based on publicly available information

Rhodri Smith

University of Alberta

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
CMCarlos D. Martins
Carlos D. Martins
CPChiara Da Pieve
Chiara Da Pieve
TBThomas A. Burley
Thomas A. Burley
RSRhodri Smith
Rhodri Smith
DCDaniela M. Ciobota
Daniela M. Ciobota
Gabriela Kramer-MarekGabriela Kramer-Marek
Gabriela Kramer-Marek
Purpose: Recent studies have highlighted a role of HER3 in HER2-driven cancers (e.g., breast cancer), implicating the upregulation of the receptor in resistance to HER-targeted therapies and Hsp90 inhibitors (e.g., AUY922). Therefore, we have developed an affibody-based PET radioconjugate that quantitatively assesses HER3 changes induced by Hsp90 inhibition in vivo. Experimental Design: ZHER3:8698 affibody molecules were conjugated via the C-terminus cysteine to DFO-maleimide for 89Zr radiolabeling. The probe was characterized in vitro and in vivo in a panel of human breast cell lines and xenograft models with varying HER3 receptor levels. In addition, the radioconjugate was investigated as a tool to monitor the outcome of AUY922, an Hsp90 inhibitor, in an MCF-7 xenograft model. Results: We demonstrated that 89Zr-DFO-ZHER3:8698 can track changes in receptor expression in HER3-positive xenograft models and monitor the outcome of AUY922 treatment. Our in vitro findings showed that MCF-7 cells, which are phenotypically different from BT474, develop resistance to treatment with AUY922 through HER3/IGF-1Rβ–mediated signaling. Of note, the lack of response in vitro due to HER3 recovery was confirmed in vivo using 89Zr-DFO-ZHER3:8698–based imaging. Upon AUY922 treatment, higher radioconjugate uptake was detected in treated MCF-7 xenografts, correlating with an AUY922-induced HER3 upregulation concomitant with an increase in IGF-1Rβ expression. Conclusions: These data underline the potential of HER3-based PET imaging to noninvasively provide information about HER3 expression and to identify patients not responding to targeted therapies due to HER3 recovery. Clin Cancer Res; 24(8); 1853–65. ©2018 AACR.

20 February 2024 in Biomedical Physics & Engineering Express
Verified
Journal Article
Open access
RSRhodri Lyn Smith
Rhodri Lyn Smith
LBLee Bartley
Lee Bartley
COChristopher O’cAllaghan
Christopher O’cAllaghan
LHLuiza Haberska
Luiza Haberska
CMChris Marshall
Chris Marshall
A performance evaluation was conducted on the new General Electric (GE) digital Omni Legend PET-CT system with 32 cm extended field of view. The first commercially available clinical digital bismuth germanate system. The system does not use time of flight (ToF). Testing was performed in accordance with the NEMA NU2–2018 standard. A comparison was made between two other commercial GE scanners with extended fields of view; the Discovery MI − 6 ring (ToF enabled) and the Discovery IQ (non-ToF). A genetic evolutionary algorithm was developed to optimize image reconstruction parameters from image quality assessments. The Omni demonstrated average spatial resolutions at 1 cm radial offset as 3.9 mm FWHM. The total system sensitivity at the center was 44.36 cps/kBq. The peak NECR was measured as 501 kcps at 17.8 kBq ml−1 with a 35.48% scatter fraction. The maximum count-rate error below NECR peak was 5.5%. Using standard iterative reconstructions, sphere contrast recovery coefficients were from 52.7 ± 3.2% (10 mm) to 92.5 ± 2.4% (37 mm). The PET-CT co-registration accuracy was 2.4 mm. In place of ToF, the Omni employs software corrections through a pre-trained neural network (PDL) (trained on non-ToF to ToF) that takes Bayesian penalized likelihood reconstruction (Q.Clear) images as input. The optimum parameters for image reconstruction, determined using the genetic algorithm were a Q.Clear parameter, β, of 350 and a ‘medium’ PDL setting. Using standard iterative reconstructions, the Omni initially showed increased background variability compared to the Discovery MI. With optimized PDL reconstruction parameters selected using the genetic algorithm the performance of the Omni surpassed that of the Discovery MI on all NEMA tests. The genetic algorithm’s demonstrated ability to enhance image quality in PET-CT imaging underscores the importance of algorithm driven optimization and underscores the requirement to validate its use in the clinical setting.

2 November 2018 in IEEE Transactions on Radiation and Plasma Medical Sciences
Verified
Journal Article
Closed access
RSRhodri L. Smith
Rhodri L. Smith
ARAshrani Aizzudin Abd Rahni
Ashrani Aizzudin Abd Rahni
JJJohn Jones
John Jones
KWKevin Wells
Kevin Wells
Respiratory motion degrades quantitative and qualitative analysis of medical images. Estimation and hence correction of motion commonly uses static correspondence models between an external surrogate signal and internal motion. This work presents a patient specific respiratory motion model with the ability to adapt in the presence of irregular motion via a Kalman filter with Expectation Maximisation for parameter estimation. The adaptive approach introduces generalizability allowing the model to account for a broader variety of motion. This may be required in the presence of irregular breathing and with different sensors monitoring the external surrogate signal. The motion model framework utilizing an adaptive Kalman filter approach is tested on dynamic MRI data of nine volunteers and compared to a state-of-the-art static total least squares approach. Results demonstrate the framework is capable of reducing motion to the order of < 3mm and is significantly (p<0.001) more effective in the presence of irregular motion, assessed using the F test for model comparison. Utilizing the total sum of squares of estimated vector field error from the calculated ground truth, we observe approximately a fifty percent reduction in root mean square error and thirty percent reduction in standard deviation utilizing the Kalman model (EKF) in comparison to a static counterpart.

15 March 2019
Verified
Conference Paper
Closed access
PDF file
IAIan Ackerley
Ian Ackerley
ESEmiliano Spezi
Emiliano Spezi
VPVineet Prakash
Vineet Prakash
RSRhodri L. Smith
Rhodri L. Smith
JSJames W. Scuffham
James W. Scuffham
KWKevin Wells
Kevin Wells
PET-CT scans using 18F-FDG are increasingly used to detect cancer, but interpretation can be challenging due to non-specific uptake and complex anatomical structures nearby. To aide this process, we investigate the potential of automated detection of lesions in 18F-FDG scans using deep learning tools. A 5-layer convolutional neural network (CNN) with 2x2 kernels, rectified linear unit (ReLU) activations and two dense layers was trained to detect cancerous lesions in 2D axial image segments from PET scans. Pre-contoured scans from a retrospective cohort study of 480 oesophageal cancer patients were split 80:10:10 into training, validation and test sets. These were then used to generate a total of ~14000 45×45 pixel image segments, where tumor present segments were centered on the marked lesion, and tumor absent segments were randomly located outside the marked lesion. ROC curves generated from the training and validation datasets produced an average AUC of ~<95%.

1 October 2012
Verified
Conference Paper
Closed access
RSRhodri L Smith
Rhodri L Smith
ARAshrani Abd Rahni
Ashrani Abd Rahni
JJJohn Jones
John Jones
KWKevin Wells
Kevin Wells
Respiratory motion correction degrades quantitatively and qualitatively Nuclear Medicine images. We propose that adaptive approaches are required to correct for the irregular breathing patterns often encountered in the clinical setting, which can be addressed within a Bayesian tracking formulation. This allows inference of the hidden organ configurations using only knowledge of an external observation such as a parametrized external surface. The flexible framework described provides a method to correct for organ motion whilst accommodating for irregular unseen respiratory patterns. In this work we utilize a Kalman filter and compare it with a Particle filter. A novel adaptive state transition model is also introduced to describe the evolution of organ configurations. The Kalman filter marginally outperforms the Particle filter, both approaches however offer an effective motion correction mechanism, correcting for motion with errors of around 1-3mm. We present results of simulated PET images derived from XCAT to demonstrate the efficacy of the approach.

13 March 2013
Verified
Conference Paper
Closed access
PDF file
ARAshrani Aizzuddin Abd. Rahni
Ashrani Aizzuddin Abd. Rahni
RSRhodri Smith
Rhodri Smith
ELEmma Lewis
Emma Lewis
KWKevin Wells
Kevin Wells